Clinical Trial Update: E-B-FAHF-2, Multi OIT and Xolair for Food Allergy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for E-B-FAHF-2, Multi OIT and Xolair in food allergy has completed recruitment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Food Allergy

Drugs mentioned

• E-B-FAHF-2
• Multi OIT
• Xolair (omalizumab)

Snippet

Sponsor: New York Medical College | Conditions: Food Allergy | Phase 2 | Status: COMPLETED